72 related articles for article (PubMed ID: 21103697)
1. FGF-23: state of the art.
Oliveira RB; Moysés RM
J Bras Nefrol; 2010; 32(3):323-31. PubMed ID: 21103697
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.
Gutierrez O; Isakova T; Rhee E; Shah A; Holmes J; Collerone G; Jüppner H; Wolf M
J Am Soc Nephrol; 2005 Jul; 16(7):2205-15. PubMed ID: 15917335
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 23 in chronic kidney disease: New insights and clinical implications.
Damasiewicz MJ; Toussaint ND; Polkinghorne KR
Nephrology (Carlton); 2011 Mar; 16(3):261-8. PubMed ID: 21265930
[TBL] [Abstract][Full Text] [Related]
4. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
Stubbs J; Liu S; Quarles LD
Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
[TBL] [Abstract][Full Text] [Related]
5. Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism.
Sato T; Tominaga Y; Ueki T; Goto N; Matsuoka S; Katayama A; Haba T; Uchida K; Nakanishi S; Kazama JJ; Gejyo F; Yamashita T; Fukagawa M
Am J Kidney Dis; 2004 Sep; 44(3):481-7. PubMed ID: 15332221
[TBL] [Abstract][Full Text] [Related]
6. The bone-renal axis in early chronic kidney disease: an emerging paradigm.
Danziger J
Nephrol Dial Transplant; 2008 Sep; 23(9):2733-7. PubMed ID: 18469306
[No Abstract] [Full Text] [Related]
7. New insights into the role of fibroblast growth factor 23 in chronic kidney disease.
Nakai K; Komaba H; Fukagawa M
J Nephrol; 2010; 23(6):619-25. PubMed ID: 20658451
[TBL] [Abstract][Full Text] [Related]
8. Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1alpha,25-dihydroxyvitamin D3 synthesis in leptin-deficient mice.
Tsuji K; Maeda T; Kawane T; Matsunuma A; Horiuchi N
J Bone Miner Res; 2010 Aug; 25(8):1711-23. PubMed ID: 20200981
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor 23 and the bone-vascular axis: lessons learned from animal studies.
Zoppellaro G; Faggin E; Puato M; Pauletto P; Rattazzi M
Am J Kidney Dis; 2012 Jan; 59(1):135-44. PubMed ID: 22070851
[TBL] [Abstract][Full Text] [Related]
10. FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment.
Seiler S; Reichart B; Roth D; Seibert E; Fliser D; Heine GH
Nephrol Dial Transplant; 2010 Dec; 25(12):3983-9. PubMed ID: 20525642
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D.
Collins MT; Lindsay JR; Jain A; Kelly MH; Cutler CM; Weinstein LS; Liu J; Fedarko NS; Winer KK
J Bone Miner Res; 2005 Nov; 20(11):1944-50. PubMed ID: 16234967
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.
Gutiérrez OM
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1710-6. PubMed ID: 20507957
[TBL] [Abstract][Full Text] [Related]
13. [Novel phosphate-regulating hormone, fibroblast growth factor (FGF) 23].
Fukumoto S
Nihon Rinsho; 2007 Nov; 65 Suppl 9():101-4. PubMed ID: 18161090
[No Abstract] [Full Text] [Related]
14. With or without the kidney: the role of FGF23 in CKD.
Fukagawa M; Kazama JJ
Nephrol Dial Transplant; 2005 Jul; 20(7):1295-8. PubMed ID: 15840677
[No Abstract] [Full Text] [Related]
15. Fibroblast growth factor 23 and matrix-metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease?
Peiskerová M; Kalousová M; Kratochvílová M; Dusilová-Sulková S; Uhrová J; Bandúr S; Malbohan IM; Zima T; Tesar V
Kidney Blood Press Res; 2009; 32(4):276-83. PubMed ID: 19797911
[TBL] [Abstract][Full Text] [Related]
16. PTH, FGF-23 and early CKD.
Rodriguez M; Felsenfeld AJ
Nephrol Dial Transplant; 2008 Nov; 23(11):3391-3. PubMed ID: 18676347
[No Abstract] [Full Text] [Related]
17. Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system.
Prié D; Friedlander G
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1717-22. PubMed ID: 20798257
[TBL] [Abstract][Full Text] [Related]
18. [Fibroblast growth factor 23 (FGF 23): a new fosfaturic hormone?].
Negri AL
Nefrologia; 2003; 23(6):478-81. PubMed ID: 15002780
[No Abstract] [Full Text] [Related]
19. Fibroblast growth factor 23 acts on the parathyroid to decrease parathyroid hormone secretion.
Galitzer H; Ben-Dov I; Lavi-Moshayoff V; Naveh-Many T; Silver J
Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):363-7. PubMed ID: 18660671
[TBL] [Abstract][Full Text] [Related]
20. Klotho gene, phosphocalcic metabolism, and survival in dialysis.
Torres PU; Prié D; Beck L; De Brauwere D; Leroy C; Friedlander G
J Ren Nutr; 2009 Jan; 19(1):50-6. PubMed ID: 19121771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
